Intercalation process of anticancer copper (II) complexes in DNA

Intercalation processes of copper complexes in DNA

The family of anticancer complexes that include the transition metal copper known as Casiopeínas® shows promising results. Two of these complexes are currently in clinical trials. The interaction of these compounds with DNA has been observed experimentally and several hypotheses regarding the mechanism of action have been developed, and these include the generation of reactive oxygen species, p...

In Vitro DNA-Binding, Anti-Oxidant and Anticancer Activity of Indole-2-Carboxylic Acid Dinuclear Copper(II) Complexes.

Indole-2-carboxylic acid copper complex (ICA-Cu) was successfully prepared and characterized through elemental analysis, IR, UV-Vis, ¹H-NMR, TG analysis, and molar conductance, and its molecular formula was [Cu₂(C₉H₆O₂N)₄(H₂O)₂]·2H₂O. The binding ability of ICA-Cu to calf thymus DNA (CT-DNA) was examined by fluorescence spectrometry and the viscosity method. The results indicated that, upon the...

Synthesis of Binuclear Copper (II) Complexes with Expanded Porphyrins

The synthesis and characterization of some new binuclear copper (II) complexes, based on the use of large, pyrole-containing macrocycles, the so called "expanded porphyrins", [Cu2(macrocycle)]+4 is described. Electron Spin Resonance (ESR) studies indicate a weak "half-field line", which is characteristic of the Cu(II)-Cu(II) dimer, is observed at about 1600G. The obser...

TEMPLATE SYNTHESIS, CHARACTERIZATION OF HIGHLY UNSYMMETRICAL TETRADENTATE SCHIFF BASE COMPLEXES OF NICKEL (II) AND COPPER (II)

Nickel (II) and copper (II) complexes of highly unsymmetrical tetradentate Schiff base have been synthesized by the template reaction of half-units N-(1-hydroxy-2-acetonaphtone)-1-amino-2-phenyleneimine (HL) and N-(2-hydroxyacetophenone)-1-amino-2-phenyleneimine (HL1) with the glyoxalphenylhydrazone. The complexes have been characterized by elemental analyses, conductance, IR, 1H NMR and UV spe...

evaluation of oxidative dna cleavage of copper (ii) complexes as chemotherapeutic agents